This includes not only the attachment of their viral particles but also the lipid-transfer functions of SR-BI, since blocking of SR-BI with antibodies and of lipid transfer with pharmacological SR-BI antagonists could readily prevent virus entry as well as the HDL-mediated enhancement of infection for either virus type (42, 43, 67, 70). Here, SCARB1 is linked to infection.